⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT

Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT

Unclaimed

AEO Score: 5/10

Monitoring for AI engine activity

In the Engagemii AEO index

orfadin.com

Share

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT just got measured.

5/10 means Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT

Learn about Orfadin® (nitisinone), the first FDA-approved treatment for hereditary tyrosinemia type 1 (HT-1), and our patient support services.

Key Topics

the orfadin generation
stay updated

Details

Industry: Healthcare

orfadin.com

AI Visibility Breakdown

1

Structured Data

6

Content Structure

6

Entity Clarity

5

E-E-A-T Signals

6

Technical AEO

4

AI Discoverability

Is this your brand?

Claim free. You'll see:

Your full 6-category score breakdown

Exact fixes: robots.txt, schema, llms.txt

AI bot crawls from ChatGPT, Claude, Perplexity, Gemini

Personal 50% off code at checkout

Already have an account? Sign in

Picked for Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT: Health & Wellness

Trust Is the Product. AI Is How You Build It at Scale.

In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT.

Source & Attribution

Scored by Engagemii on June 27, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/orfadin

Cite this score: Engagemii (2026). "AEO Score for Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT." Retrieved from https://engagemii.com/aeo/brands/orfadin

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - AI Brand Discovery and AEO Platform